- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 1.3 | 1.84 | 1.31 | 13.75 | -20.3 | 3.74 | N/A | - | ||
| 2024/10 | 1.27 | 8.53 | -1.82 | 12.46 | -22.03 | 3.74 | N/A | - | ||
| 2024/9 | 1.17 | -9.53 | -11.04 | 11.18 | -23.81 | 3.66 | 1.9 | - | ||
| 2024/8 | 1.3 | 8.24 | -14.06 | 10.01 | -25.07 | 3.93 | 1.77 | - | ||
| 2024/7 | 1.2 | -16.8 | -24.67 | 8.72 | -26.47 | 3.88 | 1.79 | - | ||
| 2024/6 | 1.44 | 15.09 | -22.1 | 7.52 | -26.75 | 4.14 | 1.81 | - | ||
| 2024/5 | 1.25 | -14.0 | -5.62 | 6.08 | -27.76 | 3.95 | 1.9 | - | ||
| 2024/4 | 1.45 | 16.06 | 15.61 | 4.83 | -31.89 | 3.7 | 2.03 | - | ||
| 2024/3 | 1.25 | 26.25 | -41.13 | 3.38 | -42.12 | 3.38 | 2.64 | - | ||
| 2024/2 | 0.99 | -12.71 | -44.86 | 2.13 | -42.69 | 3.4 | 2.62 | - | ||
| 2024/1 | 1.14 | -10.88 | -40.65 | 1.14 | -40.65 | 3.69 | 2.42 | - | ||
| 2023/12 | 1.27 | -0.26 | -32.97 | 18.53 | -26.35 | 3.85 | 2.37 | - | ||
| 2023/11 | 1.28 | -1.31 | 22.96 | 17.25 | -25.81 | 3.89 | 2.34 | - | ||
| 2023/10 | 1.3 | -1.65 | 24.5 | 15.98 | -28.1 | 4.12 | 2.21 | - | ||
| 2023/9 | 1.32 | -12.6 | -27.57 | 14.68 | -30.68 | 4.41 | 2.23 | - | ||
| 2023/8 | 1.51 | -5.12 | -27.8 | 13.36 | -30.97 | 4.94 | 1.99 | - | ||
| 2023/7 | 1.59 | -13.96 | -30.43 | 11.86 | -31.36 | 4.76 | 2.07 | - | ||
| 2023/6 | 1.85 | 39.43 | -27.95 | 10.27 | -31.5 | 4.43 | 2.44 | - | ||
| 2023/5 | 1.32 | 5.34 | -48.85 | 8.42 | -32.23 | 4.71 | 2.29 | - | ||
| 2023/4 | 1.26 | -40.9 | -49.91 | 7.1 | -27.85 | 5.18 | 2.08 | - | ||
| 2023/3 | 2.13 | 18.26 | -14.66 | 5.84 | -20.3 | 5.84 | 2.02 | - | ||
| 2023/2 | 1.8 | -6.05 | -19.38 | 3.71 | -23.2 | 5.62 | 2.1 | - | ||
| 2023/1 | 1.91 | 0.63 | -26.48 | 1.91 | -26.48 | 4.86 | 2.43 | - | ||
| 2022/12 | 1.9 | 82.98 | -23.66 | 25.16 | -6.4 | 3.98 | 3.57 | - | ||
| 2022/11 | 1.04 | -0.07 | -61.73 | 23.26 | -4.64 | 3.9 | 3.64 | 單月營收減少係訂單需求減緩所致 | ||
| 2022/10 | 1.04 | -42.79 | -62.08 | 22.22 | 2.51 | 4.95 | 2.87 | 單月營收減少係訂單需求減緩所致 | ||
| 2022/9 | 1.82 | -12.87 | -37.26 | 21.18 | 11.87 | 6.19 | 2.23 | - | ||
| 2022/8 | 2.09 | -8.58 | -21.0 | 19.36 | 20.76 | 6.93 | 1.99 | - | ||
| 2022/7 | 2.28 | -10.89 | -14.34 | 17.27 | 29.0 | 7.44 | 1.86 | - | ||
| 2022/6 | 2.56 | -1.02 | 32.43 | 14.99 | 39.78 | 7.66 | 1.54 | - | ||
| 2022/5 | 2.59 | 3.16 | 36.08 | 12.43 | 41.39 | 7.59 | 1.56 | - | ||
| 2022/4 | 2.51 | 0.69 | 34.22 | 9.84 | 42.86 | 7.23 | 1.64 | - | ||
| 2022/3 | 2.49 | 11.72 | 35.06 | 7.33 | 46.08 | 7.33 | 1.08 | - | ||
| 2022/2 | 2.23 | -14.32 | 41.58 | 4.83 | 52.5 | 7.33 | 1.08 | 單月及全年累計營收增加係訂單需求成長所致 | ||
| 2022/1 | 2.6 | 4.49 | 63.28 | 2.6 | 63.28 | 7.81 | 1.01 | 單月及全年累計營收增加係訂單需求成長所致 | ||
| 2021/12 | 2.49 | -8.28 | 63.65 | 26.88 | 100.79 | 7.95 | 0.69 | 單月及全年累計營收增加係訂單需求成長所致。 | ||
| 2021/11 | 2.72 | -0.97 | 72.19 | 24.39 | 105.55 | 8.36 | 0.66 | 單月及全年累計營收增加係訂單需求成長所致。 | ||
| 2021/10 | 2.74 | -5.36 | 108.44 | 21.67 | 110.67 | 8.29 | 0.66 | 單月及全年累計營收增加係訂單需求成長所致。 | ||
| 2021/9 | 2.9 | 9.69 | 109.47 | 18.93 | 111.0 | 8.21 | 0.47 | 單月及全年累計營收增加係訂單需求成長所致。 | ||
| 2021/8 | 2.64 | -0.86 | 124.15 | 16.03 | 111.28 | 7.24 | 0.53 | 單月及全年累計營收增加係訂單需求成長所致。 | ||
| 2021/7 | 2.67 | 37.76 | 164.78 | 13.39 | 108.91 | 6.5 | 0.59 | 單月及全年累計營收增加係訂單需求成長所致。 | ||
| 2021/6 | 1.94 | 1.7 | 102.4 | 10.72 | 98.5 | 5.71 | 0.53 | 單月及全年累計營收增加係訂單需求成長所致。 | ||
| 2021/5 | 1.9 | 1.75 | 111.94 | 8.79 | 97.66 | 5.62 | 0.54 | 單月及全年累計營收增加係訂單需求成長所致。 | ||
| 2021/4 | 1.87 | 1.32 | 152.61 | 6.89 | 94.04 | 5.29 | 0.57 | 本月營收較去年同期增加係訂單需求成長所致。 | ||
| 2021/3 | 1.85 | 17.11 | 41.41 | 5.02 | 78.6 | 5.02 | 0.47 | 因新冠肺炎疫情趨於穩定且訂單需求成長所致。 | ||
| 2021/2 | 1.58 | -1.19 | 95.59 | 3.17 | 110.89 | 4.69 | 0.5 | 因新冠肺炎疫情趨於穩定且訂單需求成長，故單月及全年累計營收較去年同期增加。 | ||
| 2021/1 | 1.59 | 4.73 | 128.55 | 1.59 | 128.55 | 4.7 | 0.5 | 係2020年新冠肺炎延後至2021年出貨所致。 | ||
| 2020/12 | 1.52 | -3.5 | 32.63 | 13.39 | 11.95 | 4.42 | 0.63 | - | ||
| 2020/11 | 1.58 | 19.87 | 56.06 | 11.87 | 9.75 | 4.28 | 0.65 | 係新冠肺炎上半年延後出貨及合併主體較去年增加所致。 | ||
| 2020/10 | 1.32 | -4.89 | 52.61 | 10.29 | 4.97 | 3.88 | 0.72 | 係新冠肺炎上半年延後出貨所致。 | ||
| 2020/9 | 1.38 | 17.39 | 22.58 | 8.97 | 0.38 | 3.57 | 0.89 | - | ||
| 2020/8 | 1.18 | 17.1 | 23.24 | 7.59 | -2.82 | 3.14 | 1.02 | - | ||
| 2020/7 | 1.01 | 5.3 | 19.38 | 6.41 | -6.46 | 2.86 | 1.12 | - | ||
| 2020/6 | 0.96 | 6.49 | 7.07 | 5.4 | -10.09 | 2.59 | 1.51 | - | ||
| 2020/5 | 0.9 | 21.27 | -8.25 | 4.45 | -13.09 | 2.94 | 1.33 | - | ||
| 2020/4 | 0.74 | -43.27 | -15.59 | 3.55 | -14.23 | 2.85 | 1.37 | - | ||
| 2020/3 | 1.3 | 61.98 | 22.32 | 2.81 | -13.87 | 2.81 | 1.41 | - | ||
| 2020/2 | 0.81 | 15.45 | -13.91 | 1.5 | -31.47 | 2.65 | 1.49 | - | ||
| 2020/1 | 0.7 | -39.22 | -44.53 | 0.7 | -44.53 | 0.0 | N/A | - | ||
| 2019/12 | 1.15 | 13.55 | 4.17 | 11.96 | -7.62 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/1 | 1.14 | 2023/1 | 1.91 | 2022/1 | 2.6 | 2021/1 | 1.59 | 2020/1 | 0.7 |
| 2024/2 | 0.99 | 2023/2 | 1.8 | 2022/2 | 2.23 | 2021/2 | 1.58 | 2020/2 | 0.81 |
| 2024/3 | 1.25 | 2023/3 | 2.13 | 2022/3 | 2.49 | 2021/3 | 1.85 | 2020/3 | 1.3 |
| 2024/4 | 1.45 | 2023/4 | 1.26 | 2022/4 | 2.51 | 2021/4 | 1.87 | 2020/4 | 0.74 |
| 2024/5 | 1.25 | 2023/5 | 1.32 | 2022/5 | 2.59 | 2021/5 | 1.9 | 2020/5 | 0.9 |
| 2024/6 | 1.44 | 2023/6 | 1.85 | 2022/6 | 2.56 | 2021/6 | 1.94 | 2020/6 | 0.96 |
| 2024/7 | 1.2 | 2023/7 | 1.59 | 2022/7 | 2.28 | 2021/7 | 2.67 | 2020/7 | 1.01 |
| 2024/8 | 1.3 | 2023/8 | 1.51 | 2022/8 | 2.09 | 2021/8 | 2.64 | 2020/8 | 1.18 |
| 2024/9 | 1.17 | 2023/9 | 1.32 | 2022/9 | 1.82 | 2021/9 | 2.9 | 2020/9 | 1.38 |
| 2024/10 | 1.27 | 2023/10 | 1.3 | 2022/10 | 1.04 | 2021/10 | 2.74 | 2020/10 | 1.32 |
| 2024/11 | 1.3 | 2023/11 | 1.28 | 2022/11 | 1.04 | 2021/11 | 2.72 | 2020/11 | 1.58 |
| N/A | N/A | 2023/12 | 1.27 | 2022/12 | 1.9 | 2021/12 | 2.49 | 2020/12 | 1.52 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 24Q3 (20) | 0.05 | -28.57 | -80.0 |
| 24Q2 (19) | 0.07 | -77.42 | -77.42 |
| 24Q1 (18) | 0.31 | 24.0 | 3.33 |
| 23Q4 (17) | 0.25 | 0.0 | -77.88 |
| 23Q3 (16) | 0.25 | -19.35 | -83.11 |
| 23Q2 (15) | 0.31 | 3.33 | -61.25 |
| 23Q1 (14) | 0.3 | -73.45 | -63.41 |
| 22Q4 (13) | 1.13 | -23.65 | 24.18 |
| 22Q3 (12) | 1.48 | 85.0 | 97.33 |
| 22Q2 (11) | 0.8 | -2.44 | 70.21 |
| 22Q1 (10) | 0.82 | -9.89 | 64.0 |
| 21Q4 (9) | 0.91 | 21.33 | 213.79 |
| 21Q3 (8) | 0.75 | 59.57 | 70.45 |
| 21Q2 (7) | 0.47 | -6.0 | 0 |
| 21Q1 (6) | 0.5 | 72.41 | 1566.67 |
| 20Q4 (5) | 0.29 | -34.09 | 866.67 |
| 20Q3 (4) | 0.44 | 0 | 0.0 |
